No Data
No Data
Volume Change Rate Ranking (9 o'clock) - Kyukoh Yakuhin, Koshidaka HD, etc. are ranked.
In the volume change rate ranking, by comparing the volume of the most recent 5 days with the volume on the delivery day, you can understand the market participants' interests in trends such as stockpiling. Top volume change rate [as of 9:32 on October 11] (comparison with the most recent 5-day average volume) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate <2625> iFTPX Year 4 207,692 107,185.08 301.98% 0.00
Subdued, with a strong upward trend in long-term US interest rates, among other heavy factors.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to have a weak performance. In the US stock market on the 10th yesterday, the Dow Jones average fell by $57.88 (-0.14%) to 42,454.12, slightly down for the third consecutive day. The Consumer Price Index (CPI) exceeded expectations, leading to a decline in expectations of a prompt interest rate cut by the Federal Reserve Board (FRB), and the impact of a large hurricane causing a significant increase in weekly initial jobless claims, deteriorating economic outlook, acted as a drag on stock prices.
Cocorara, OncoRis Bio, and others
Amita HD, a wholly-owned subsidiary of 2195, absorbs and merges with MIDAO. Silicon Studio of 3907 downward revised its current fiscal year operating profit forecast from 25.4 billion yen to 14.8 billion yen. Cocoonala of 4176 upward revised its previous fiscal year operating profit forecast from 27 billion yen to 30.4 billion yen. Anges' gene therapy product 'Collategen' has been designated as a breakthrough therapy. Oncolis Bio's 20th new subscription rights (with revision clause on exercise price) will see a large-scale exercise starting from the 1st.
Abeja: Summary of financial results for the fiscal year ending 2024/8 [Japanese GAAP] (unconsolidated)
Abeja: Notice regarding the difference between full-year earnings forecasts and actual values
Abeja: Financial results presentation materials for the fiscal year ending 2024/8
No Data
No Data